Personalised Medicine
Oct 11,2010 - Oct 12,2010Crowne Plaza Hotel - The City, England, United Kingdom
-
Highlights
Attend SMi’s 2010 Personalised Medicine conference to study the latest developments in the science and the latest business strategies and partnership models moving the industry nearer to a personalised future. Chaired by Cecilia Schott, Director of Business Development, AstraZeneca and by Martin Wilkins, Professor of Clinical Pharmacology and Head of the Division of Experimental Medicine, Imperial College London, the conference will cover key topics such as:
- Successful partnerships in personalised medicine – Jason Coloma, Roche Molecular Diagnostics
- Partnering for companion test development: perspective of a global IVD company – Iain Miller, bioMérieux
- Current challenges in the regulatory framework – Lincoln Tsang, Arnold & Porter LLP
- Deep resequencing as a tool for drug repositioning – John Whittaker, GlaxoSmithKline
- Integrating biomarker discovery and execution – Pearl Huang, Merck
- Safety and toxicity biomarkers – Gino Miele, Pfizer
Event Reminder
- Registration Open
- Call for Papers
- Call for Speakers
- Receive GTM eblast updates
- Security Code:
Contact Details
- Contact person: Daniel Davies
- Event website: www.smi-online.co.uk/personalised13.asp
- Phone: +44 (0) 20 7827 6060
- Fax:
Contact Organizer
